These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| o |
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| x |
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| o |
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Date of event requiring this shell company report………………………………
For the transition period from ______ to ______
|
|
U.S. GAAP
x
|
International Financial Reporting Standards
as issued by the International Accounting
Standards Board
o
|
Other
o
|
|
|
·
|
statements regarding projections of capital expenditures;
|
|
|
·
|
statements regarding competitive pressures;
|
|
|
·
|
statements regarding expected revenue growth;
|
|
|
·
|
statements regarding the expected growth in the use of particular broadband applications;
|
|
|
·
|
statements as to our ability to meet anticipated cash needs based on our current business plan;
|
|
|
·
|
statements as to the impact of the rate of inflation and the political and security situation on our business;
|
|
|
·
|
statements regarding the price and market liquidity of our ordinary shares;
|
|
|
·
|
statements as to our ability to retain our current suppliers and subcontractors; and
|
|
|
·
|
statements regarding our future performance, sales, gross margins, expenses (including stock-based compensation expenses) and cost of revenues.
|
|
PART I
|
|
|
6
|
|
|
6
|
|
|
6
|
|
|
Selected Financial Data
|
6
|
|
Capitalization and Indebtedness
|
7
|
|
Reasons for Offer and Use of Proceeds
|
7
|
|
Risk Factors
|
7
|
|
19
|
|
|
History and Development of Allot
|
19
|
|
Business Overview
|
19
|
|
Organizational Structure
|
26
|
|
Property, Plants and Equipment
|
27
|
|
27
|
|
|
27
|
|
|
Operating Results
|
27
|
|
Liquidity and Capital Resources
|
39
|
|
Research and Development, Patents and Licenses
|
40
|
|
Trend Information
|
40
|
|
Off-Balance Sheet Arrangements
|
40
|
|
Contractual Obligations
|
40
|
|
41
|
|
|
Directors and Senior Management
|
41
|
|
Compensation of Officers and Directors
|
44
|
|
Board Practices
|
45
|
|
Employees
|
50
|
|
Share Ownership
|
51
|
|
53
|
|
|
Major Shareholders
|
53
|
|
Related Party Transactions
|
54
|
|
Interests of experts and counsel
|
55
|
|
55
|
|
|
Consolidated Financial Statements and Other Financial Information
|
55
|
|
Significant Changes
|
56
|
|
56
|
|
|
Stock Price History
|
56
|
|
Markets
|
57
|
|
57
|
|
|
Share Capital
|
57
|
|
Memorandum and Articles of Association
|
57
|
|
Material Contracts
|
60
|
|
Exchange Controls
|
60
|
|
Taxation
|
60
|
|
Documents on Display
|
70
|
|
Subsidiary Information
|
71
|
|
71
|
|
|
71
|
|
|
PART II
|
|
|
71
|
|
|
71
|
|
|
72
|
|
|
73
|
|
|
73
|
|
|
73
|
|
|
73
|
|
|
74
|
|
|
74
|
|
|
74
|
|
|
74
|
|
|
PART III
|
|
|
75
|
|
|
75
|
|
|
75
|
|
Year ended December 31,
|
||||||||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
||||||||||||||||
|
(in thousands of U.S. dollars, except per share and share data)
|
||||||||||||||||||||
|
Consolidated Statements of Operations:
|
||||||||||||||||||||
|
Revenues:
|
||||||||||||||||||||
|
Products
|
$ | 25,073 | $ | 27,121 | $ | 29,641 | $ | 40,852 | $ | 56,810 | ||||||||||
|
Services
|
7,429 | 9,980 | 12,110 | 16,120 | 20,943 | |||||||||||||||
|
Total revenues
|
32,502 | 37,101 | 41,751 | 56,972 | 77,753 | |||||||||||||||
|
Cost of revenues(1):
|
||||||||||||||||||||
|
Products
|
6,603 | 8,198 | 10,094 | 14,015 | 19,540 | |||||||||||||||
|
Services
|
1,416 | 1,498 | 1,741 | 1,970 | 2,635 | |||||||||||||||
|
Total cost of revenues
|
8,019 | 9,696 | 11,835 | 15,985 | 22,175 | |||||||||||||||
|
Gross profit
|
24,483 | 27,405 | 29,916 | 40,987 | 55,578 | |||||||||||||||
|
Operating expenses:
|
||||||||||||||||||||
|
Research and development, gross
|
11,755 | 14,635 | 11,705 | 14,038 | 16,896 | |||||||||||||||
|
Less royalty-bearing participation
|
2,371 | 2,671 | 2,440 | 2,774 | 3,674 | |||||||||||||||
|
Research and development, net(1)
|
9,384 | 11,964 | 9,265 | 11,264 | 13,222 | |||||||||||||||
|
Sales and marketing(1)
|
18,081 | 19,781 | 20,408 | 22,021 | 26,543 | |||||||||||||||
|
General and administrative(1)
|
5,583 | 6,174 | 5,541 | 5,473 | 7,474 | |||||||||||||||
|
In process research and development
|
- | 244 | - | - | - | |||||||||||||||
|
Total operating expenses
|
33,048 | 38,163 | 35,214 | 38,758 | 47,239 | |||||||||||||||
|
Operating income (loss)
|
(8,565 | ) | (10,758 | ) | (5,298 | ) | 2,229 | 8,339 | ||||||||||||
|
Financing income (expenses), net
|
(845 | ) | (5,517 | ) | (2,311 | ) | (7,907 | ) | 415 | |||||||||||
|
Income (loss) before income tax expenses (benefit)
|
(9,410 | ) | (16,275 | ) | (7,609 | ) | (5,678 | ) | 8,754 | |||||||||||
|
Income tax expenses (benefit)
|
530 | 220 | 63 | 84 | (55 | ) | ||||||||||||||
|
Net income (loss)
|
$ | (9,940 | ) | $ | (16,495 | ) | $ | (7,672 | ) | $ | (5,762 | ) | $ | 8,809 | ||||||
|
Basic net earnings (loss) per share
|
$ | (0.46 | ) | $ | (0.75 | ) | $ | (0.35 | ) | $ | (0.25 | ) | $ | 0.35 | ||||||
|
Diluted net earnings (loss) per share
|
$ | (0.46 | ) | $ | (0.75 | ) | $ | (0.35 | ) | $ | (0.25 | ) | $ | 0.33 | ||||||
|
Weighted average number of shares used in
computing basic net earnings (loss) per share
|
21,525,822 | 22,054,211 | 22,185,702 | 22,831,014 | 25,047,771 | |||||||||||||||
|
Weighted average number of shares used in
computing diluted net earnings (loss) per share
|
21,525,822 | 22,054,211 | 22,185,702 | 22,831,014 | 27,071,872 | |||||||||||||||
|
Year ended December 31,
|
||||||||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
||||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Cost of revenues
|
$ | 48 | $ | 50 | $ | 104 | $ | 95 | $ | 103 | ||||||||||
|
Research and development expenses, net
|
230 | 321 | 357 | 352 | 442 | |||||||||||||||
|
Sales and marketing expenses
|
340 | 465 | 775 | 851 | 1,001 | |||||||||||||||
|
General and administrative expenses
|
743 | 866 | 1,062 | 692 | 710 | |||||||||||||||
|
Total
|
$ | 1,361 | $ | 1,702 | $ | 2,298 | $ | 1,990 | $ | 2,256 | ||||||||||
|
At December 31,
|
||||||||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
||||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Consolidated balance sheet data:
|
||||||||||||||||||||
|
Cash and cash equivalents
|
$ | 28,101 | $ | 40,029 | $ | 36,470 | $ | 42,858 | $ | 116,682 | ||||||||||
|
Short-term deposits and restricted deposits
|
62 | 2,121 | 2,324 | 1,060 | 25,138 | |||||||||||||||
|
Marketable securities
|
42,614 | 15,319 | 14,490 | 15,531 | 17,580 | |||||||||||||||
|
Working capital
|
37,225 | 40,688 | 38,179 | 59,841 | 158,937 | |||||||||||||||
|
Total assets
|
94,655 | 82,851 | 82,943 | 95,187 | 197,058 | |||||||||||||||
|
Total liabilities
|
17,470 | 19,672 | 22,531 | 30,199 | 34,489 | |||||||||||||||
|
Accumulated deficit
|
(47,208 | ) | (63,703 | ) | (63,694 | ) | (69,456 | ) | (60,647 | ) | ||||||||||
|
Share capital
|
480 | 482 | 492 | 527 | 720 | |||||||||||||||
|
Total shareholders’ equity
|
77,185 | 63,179 | 60,412 | 64,988 | 162,569 | |||||||||||||||
|
|
·
|
substantial cash expenditures;
|
|
|
·
|
potentially dilutive issuances of equity securities;
|
|
|
·
|
the incurrence of debt and contingent liabilities;
|
|
|
·
|
a decrease in our profit margins; and
|
|
|
·
|
amortization of intangibles and potential impairment of goodwill.
|
|
|
·
|
current or future U.S. or foreign patents applications will be approved;
|
|
|
·
|
our issued patents will protect our intellectual property and not be held invalid or unenforceable if challenged by third
-
parties;
|
|
|
·
|
we will succeed in protecting our technology adequately in all key jurisdictions in which we or our competitors operate;
|
|
|
·
|
the patents of others will not have an adverse effect on our ability to do business; or
|
|
|
·
|
others will not independently develop similar or competing products or methods or design around any patents that may be issued to us.
|
|
|
·
|
announcements or introductions of technological innovations
,
new products, product enhancements or pricing policies by us or our competitors;
|
|
|
·
|
winning or losing contracts with service providers;
|
|
|
·
|
disputes or other developments with respect to our or our competitors’ intellectual property rights;
|
|
|
·
|
announcements of strategic partnerships, joint ventures or other agreements by us or our competitors;
|
|
|
·
|
recruitment or departure of key personnel;
|
|
|
·
|
regulatory developments in the markets in which we sell our products;
|
|
|
·
|
our sale of ordinary shares or other securities in the future;
|
|
|
·
|
changes in the estimation of the future size and growth of our markets; or
|
|
|
·
|
market conditions in our industry, the industries of our customers and the economy as a whole.
|
|
Series
|
Target Market
|
|
NetEnforcer AC-400/AC-500
|
Small to medium enterprise networks and service provider networks
|
|
NetEnforcer AC-1400/ AC-3000
|
Carrier-class solutions used by large enterprise networks and medium and large service provider networks
|
|
Service Gateway –Sigma and Sigma E
|
Carrier-class solutions used by medium and large service provider networks
|
|
_______________________
|
|
|
·
|
unlimited 24/7 access to Allot’s support organization, via phone, emails and online support system;
|
|
|
·
|
expedited replacement units in the event of a warranty claim;
|
|
|
·
|
software updates and upgrades offering new features and addressing new and changing network applications; and
|
|
|
·
|
periodical updates of solution documentation and technical information.
|
|
Year Ended December 31,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
United States
|
15 | % | 14 | % | 12 | % | ||||||
|
Europe
|
45 | 53 | 50 | |||||||||
|
Asia and Oceania
|
26 | 22 | 17 | |||||||||
|
Middle East and Africa
|
7 | 7 | 12 | |||||||||
|
Americas (excluding United States)
|
7 | 4 | 9 | |||||||||
|
Total
|
100 | % | 100 | % | 100 | % | ||||||
|
Year Ended December 31,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
Revenues:
|
||||||||||||
|
Products
|
71.0 | % | 71.7 | % | 73.1 | % | ||||||
|
Services
|
29.0 | 28.3 | 26.9 | |||||||||
|
Total revenues
|
100.0 | 100.0 | 100.0 | |||||||||
|
Cost of revenues:
|
||||||||||||
|
Products
|
24.2 | 24.6 | 25.1 | |||||||||
|
Services
|
4.2 | 3.5 | 3.4 | |||||||||
|
Total cost of revenues
|
28.4 | 28.1 | 28.5 | |||||||||
|
Gross profit
|
71.6 | 71.9 | 71.5 | |||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development, net
|
22.1 | 19.8 | 17.1 | |||||||||
|
Sales and marketing
|
48.9 | 38.7 | 34.1 | |||||||||
|
General and administrative
|
13.3 | 9.6 | 9.6 | |||||||||
|
Total operating expenses
|
84.3 | 68.1 | 60.8 | |||||||||
|
Operating profit ( loss)
|
(12.7 | ) | 3.8 | 10.7 | ||||||||
|
Financing income (expenses), net
|
(5.5 | ) | (13.8 | ) | 0.5 | |||||||
|
Profit (loss) before income tax expense (benefit)
|
(18.2 | ) | (10.0 | ) | 11.2 | |||||||
|
Income tax expense (benefit)
|
0.1 | 0.1 | (0.1 | ) | ||||||||
|
Net profit (loss)
|
(18.3 | )% | (10.1 | )% | 11.3 | % | ||||||
|
Payments due by period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
Less than 1 year
|
1– 3 years
|
3-5 years
|
Over 5 years
|
|||||||||||||||
|
(in thousands of U.S. dollars)
|
||||||||||||||||||||
|
Operating leases — offices(1)
|
$ | 1,610 | $ | 922 | $ | 633 | $ | 55 | $ | - | ||||||||||
|
Operating leases — vehicles
|
564 | 314 | 250 | - | - | |||||||||||||||
|
Purchase obligations
|
2,566 | 2,566 | - | - | - | |||||||||||||||
|
Accrued severance pay(2)
|
219 | - | - | - | 219 | |||||||||||||||
|
Other(3)
|
75 | 75 | - | - | - | |||||||||||||||
|
Total
|
5,034 | 3,877 | 883 | 55 | 219 | |||||||||||||||
|
(1)
|
Consists primarily of an operating lease for our facilities in Hod Hasharon, Israel, as well as operating leases for facilities leased by our subsidiaries.
|
|
(2)
|
Severance pay relates to accrued severance obligations to our Israeli employees as required under Israeli labor law. These obligations are payable only upon termination, retirement or death of the respective employee and there is no obligation if the employee voluntarily resigns. Of this amount, $0.2 million is unfunded.
|
|
(3)
|
Uncertain income tax position under FASB ASC No. 740-10, “Income Taxes,” (originally issued as FIN 48) is due upon settlement, and we are unable to reasonably estimate the ultimate amount or timing of settlement. See Note 13 to our consolidated financial statements included elsewhere in this annual report for further information regarding our liability under ASC No. 740-10.
|
|
Name
|
Age
|
Position
|
|
Directors
|
||
|
Shraga Katz
|
59
|
Chairman of the Board
|
|
Rami Hadar
|
48
|
Director, Chief Executive Officer and President
|
|
Itzhak Danziger(1)
|
63
|
Director
|
|
Nurit Benjamini(1)(2)
|
45
|
Director
|
|
Steven D. Levy(2)
|
56
|
Director
|
|
Yigal Jacoby
|
51
|
Director
|
|
Executive Officers
|
||
|
Nachum Falek
|
41
|
Chief Financial Officer
|
|
Amir Hochbaum
|
52
|
Vice President — Research and Development
|
|
Anat Shenig
|
43
|
Vice President — Human Resources
|
|
Andrei Elefant
|
38
|
Vice President — Product Management and Marketing
|
|
Eli Cohen
|
44
|
Vice President — International Sales
|
|
Jay Klein
|
48
|
Vice President — Chief Technology Officer
|
|
Lior Moyal
|
41
|
Vice President — Business Development
|
|
Pini Gvili
|
46
|
Vice President — Operations
|
|
Ramy Moriah
|
56
|
Vice President — Customer Care and Information Technology
|
|
Vin Costello
|
54
|
Vice President and General Manager — The Americas
|
|
|
·
|
the majority of shares voted at the meeting, including at least majority the shares of non-controlling shareholder(s) and shareholders not having personal interest in the election of the outside director, voted at the meeting, excluding abstentions, vote in favor of the election of the outside director; or
|
|
|
·
|
the total number of shares of non-controlling shareholders and shareholders not having personal interest in the election of the outside director voted against the election of the outside director does not exceed two percent of the aggregate voting rights in the company.
|
|
|
·
|
the chairperson of the board of directors;
|
|
|
·
|
a controlling shareholder or a relative of a controlling shareholder (as defined in the Companies Law); or
|
|
|
·
|
any director who is engaged by, or provides services on a regular basis to the company, the company’s controlling shareholder or an entity controlled by a controlling shareholder or any director who generally relies on a controlling shareholder for his or her livelihood.
|
|
|
·
|
approval of transactions with office holders and controlling shareholders, as described above, and other related-party transactions.
|
|
|
·
|
determining the compensation of our Chief Executive Officer and other executive officers;
|
|
|
·
|
granting options to our employees and the employees of our subsidiaries;
|
|
|
·
|
recommending candidates for nomination as members of our board of directors; and
|
|
|
·
|
developing and recommending to the board corporate governance guidelines and a code of business ethics and conduct in accordance with applicable laws.
|
|
|
·
|
a breach of duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
|
|
·
|
a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;
|
|
|
·
|
an act or omission committed with intent to derive illegal personal benefit; or
|
|
|
·
|
a fine, civil fine, monetary sanction or forfeit levied against the office holder.
|
|
December 31,
|
||||||||||||
|
Department
|
2009
|
2010
|
2011
|
|||||||||
|
Manufacturing and operations
|
16 | 16 | 19 | |||||||||
|
Research and development
|
92 | 95 | 110 | |||||||||
|
Sales, marketing, service and support
|
114 | 123 | 160 | |||||||||
|
Management and administration
|
30 | 30 | 35 | |||||||||
|
Total
|
252 | 264 | 324 | |||||||||
|
Name of Beneficial Owner
|
Number of Shares
Beneficially Held(1)
|
Percent of Class
|
||||||
|
Directors
|
||||||||
|
Yigal Jacoby
|
669,658 | 2.1 | % | |||||
|
Rami Hadar
|
450,302 | 1.4 | % | |||||
|
Itzhak Danziger
|
* | * | ||||||
|
Nurit Benjamini
|
* | * | ||||||
|
Shraga Katz
|
* | * | ||||||
|
Steven D. Levy
|
* | * | ||||||
|
Executive Officers
|
||||||||
|
Amir Hochbaum
|
* | * | ||||||
|
Anat Shenig
|
* | * | ||||||
|
Andrei Elefant
|
* | * | ||||||
|
Eli Cohen
|
* | * | ||||||
|
Jay Klein
|
* | * | ||||||
|
Lior Moyal
|
* | * | ||||||
|
Nachum Falek
|
* | * | ||||||
|
Pini Gvili
|
* | * | ||||||
|
Ramy Moriah
|
* | * | ||||||
|
Vin Costello
|
* | * | ||||||
|
All directors and executive officers as a group
|
1,574,668 | 5.0 | % | |||||
|
*
|
Less than one percent of the outstanding ordinary shares.
|
|
(1)
|
As used in this table, “beneficial ownership” means the sole or shared power to vote or direct the voting or to dispose or direct the disposition of any security. For purposes of this table, a person is deemed to be the beneficial owner of securities that can be acquired within 60 days from April 10, 2012 through the exercise of any option or warrant. Ordinary shares subject to options or warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages are based upon 31,655,781 ordinary shares outstanding as of April 10, 2012.
|
|
(2)
|
Consists of 435,410 shares held by Odem Rotem Holdings Ltd., a company wholly-owned and controlled by Yigal Jacoby, 165,200 shares held by Yigal Jacoby and 61,548 shares jointly held by Yigal Jacoby and his spouse, Anat Jacoby, and an option to purchase 7,500 shares held by Yigal Jacoby.
|
|
Ordinary Shares
Beneficially
Owned
(1)
|
Percentage of
Ordinary Shares
Beneficially Owned
|
|||||||
|
Brookside Capital Fund
(2)
|
3,081,549 | 9.7 | % | |||||
|
Zohar Zisapel
(3)
|
2,842,378 | 9.0 | % | |||||
|
(1)
|
As used in this table, “beneficial ownership” means the sole or shared power to vote or direct the voting or to dispose or direct the disposition of any security. For purposes of this table, a person is deemed to be the beneficial owner of securities that can be acquired within 60 days from April 10, 2012 through the exercise of any option or warrant. Ordinary shares subject to options or warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages are based upon 31,655,781 ordinary shares outstanding as of April 10, 2012.
|
|
(2)
|
Based on a Schedule 13G/A filed on December 31, 2011. Consists of 3,081,549 shares held by Brookside Capital Partners Fund, L.P., a Delaware limited partnership. Brookside Capital Investors, L.P., a Delaware limited partnership is the sole general partner of the Brookside Capital Partners Fund, L.P. Brookside Capital Management, LLC, a Delaware limited liability company, is the sole general partner of Brookside Capital Investors, L.P. Domenic J. Ferrante is the sole managing member of Brookside Capital Management, LLC. The address of the Brookside entities is c/o John Hancock Tower, 200 Clarendon Street, Boston MA 02116.
|
|
(3)
|
Based on a Schedule 13G/A filed on January 13, 2011. Consists of 2,777,487 shares are held by Zohar Zisapel and 64,891 shares are held by Lomsha Ltd., an Israeli company controlled by Zohar Zisapel. The address of Mr. Zisapel and Lomsha Ltd. is 24 Raoul Wallenberg Street, Tel Aviv 69719, Israel.
|
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
Year
|
High
|
Low
|
High
|
Low
|
||||||||||||
|
2008
|
$ | 4.85 | 1.60 |
NIS—
|
NIS—
|
|||||||||||
|
2009
|
4.25 | 1.42 | — | — | ||||||||||||
|
2010
|
11.64 | 4.00 | 42.57 | 37.20 | ||||||||||||
|
2011
|
19.05 | 9.45 | 71.22 | 35.74 | ||||||||||||
|
2012 (through April 16, 2012)
|
24.43 | 15.55 | 92.70 | 58.56 | ||||||||||||
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
2010
|
High
|
Low
|
High
|
Low
|
||||||||||||
|
First Quarter
|
$ | 5.15 | $ | 4.00 |
NIS—
|
NIS—
|
||||||||||
|
Second Quarter
|
5.83 | 4.40 | — | — | ||||||||||||
|
Third Quarter
|
6.27 | 4.25 | — | — | ||||||||||||
|
Fourth Quarter
|
11.64 | 6.11 | 42.57 | 37.20 | ||||||||||||
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
2011
|
High
|
Low
|
High
|
Low
|
||||||||||||
|
First Quarter
|
$ | 16.16 | $ | 10.84 |
NIS58.50
|
NIS38.49
|
||||||||||
|
Second Quarter
|
18.29 | 13.31 | 63.31 | 45.16 | ||||||||||||
|
Third Quarter
|
19.05 | 9.75 | 65.28 | 35.74 | ||||||||||||
|
Fourth Quarter
|
18.47 | 9.45 | 71.22 | 36.57 | ||||||||||||
|
NASDAQ Global Market
|
Tel Aviv Stock Exchange
|
|||||||||||||||
|
Most Recent Six Months
|
High
|
Low
|
High
|
Low
|
||||||||||||
|
March 2012
|
$ | 23.25 | $ | 17.36 |
NIS86.17
|
NIS66.33
|
||||||||||
|
February 2012
|
18.63 | 15.96 | 70.1 | 59.8 | ||||||||||||
|
January 2012
|
16.64 | 15.55 | 63.29 | 58.56 | ||||||||||||
|
December 2011
|
18.47 | 15.20 | 71.22 | 59.85 | ||||||||||||
|
November 2011
|
16.86 | 14.28 | 61.95 | 50.10 | ||||||||||||
|
October 2011
|
14.28 | 9.45 | 49.97 | 36.57 | ||||||||||||
|
·
|
The duty of loyalty incumbent on an office holder requires him or her to act in good faith and for the benefit of the company, and includes, among other things, the duty to avoid conflicts of interest with the company, refrain from competing with the company and disclosing to the company information disclosed to him or her as a result of being an office holder.
|
|
Material Contract
|
Location
|
|
|
Agreement with Flextronics (Israel) Ltd
|
“ITEM 4.B: Information on the Company–Business Overview–Manufacturing.”
|
|
|
·
|
Amortization of the cost of purchased know-how and patents and of rights to use a patent and know-how which are used for the development or advancement of the company, over an eight-year period;
|
|
|
·
|
Under specified conditions, an election to file consolidated tax returns with additional related Israeli Industrial Companies; and
|
|
|
·
|
Expenses related to a public offering in Israel and in recognized stock markets outside Israel, are deductible in equal amounts over three years.
|
|
|
|
|
|
·
|
Extension of the benefit period to up to ten years.
|
|
|
·
|
An additional period of reduced corporate tax liability at rates ranging between 10% and 25%, depending on the level of foreign (that is, non-Israeli) ownership of our shares. Those tax rates and the related levels of foreign investment are as set forth in the following table:
|
|
Rate of Reduced Tax
|
Reduced Tax Period
|
Tax Exemption Period
|
Percent of Foreign Ownership
|
|||
|
25
|
0 years
|
10 years
|
0-25%
|
|||
|
25
|
0 years
|
10 years
|
25-48.99%
|
|||
|
20
|
0 years
|
10 years
|
49-73.99%
|
|||
|
15
|
0 years
|
10 years
|
74-89.99%
|
|||
|
10
|
0 years
|
10 years
|
90-100%
|
|
Rate of Reduced Tax
|
Reduced Tax Period
|
Tax Exemption Period
|
Percent of Foreign Ownership
|
|||
|
25
|
1 years
|
6 years
|
0-25%
|
|||
|
25
|
4 years
|
6 years
|
25-48.99%
|
|||
|
20
|
4 years
|
6 years
|
49-73.99%
|
|||
|
15
|
4 years
|
6 years
|
74-89.99%
|
|||
|
10
|
4 years
|
6 years
|
90-100%
|
|
Rate of Reduced Tax
|
Reduced Tax Period
|
Tax Exemption Period
|
Percent of Foreign Ownership
|
|||
|
25
|
5 years
|
2 years
|
0-25%
|
|||
|
25
|
8 years
|
2 years
|
25-48.99%
|
|||
|
20
|
8 years
|
2 years
|
49-73.99%
|
|||
|
15
|
8 years
|
2 years
|
74-89.99%
|
|||
|
10
|
8 years
|
2 years
|
90-100%
|
|
|
·
|
Similar to the currently available alternative route, exemption from corporate tax on undistributed income for a period of two to ten years, depending on the geographic location of the Benefited Enterprise within Israel, and a reduced corporate tax rate of 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in each year. Benefits may be granted for a term of seven to ten years, depending on the level of foreign investment in the company. If the company pays a dividend out of income derived from the Benefited Enterprise during the tax exemption period, such income will be subject to corporate tax at the applicable rate (10%-25%) in respect of the gross amount of the dividend that we may be distributed. The company is required to withhold tax at the source at a rate of 15% from any dividends distributed from income derived from the Benefited Enterprise; and
|
|
|
·
|
A special tax route, which enables companies owning facilities in certain geographical locations in Israel to pay corporate tax at the rate of 11.5% on income of the Benefited Enterprise. The benefits period is ten years. Upon payment of dividends, the company is required to withhold tax at source at a rate of 15% for Israeli residents and at a rate of 4% for foreign residents.
|
|
|
·
|
financial institutions or insurance companies;
|
|
|
·
|
real estate investment trusts, regulated investment companies or grantor trusts;
|
|
|
·
|
dealers or traders in securities or currencies;
|
|
|
·
|
tax-exempt entities;
|
|
|
·
|
certain former citizens or long-term residents of the United States;
|
|
|
·
|
persons that will hold our shares through a partnership or other pass-through entity;
|
|
|
·
|
persons that received our shares as compensation for the performance of services;
|
|
|
·
|
persons that will hold our shares as part of a “hedging” or “conversion” transaction or as a position in a “straddle” for United States federal income tax purposes;
|
|
|
·
|
persons whose “functional currency” is not the United States dollar; or
|
|
|
·
|
holders that own directly, indirectly or through attribution 10.0% or more of the voting power or value of our shares.
|
|
|
·
|
a citizen or resident of the United States;
|
|
|
·
|
corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any state thereof, including the District of Columbia;
|
|
|
·
|
an estate the income of which is subject to United States federal income taxation regardless of its source; or
|
|
|
·
|
a trust if such trust has validly elected to be treated as a United States person for United States federal income tax purposes or if (1) a court within the United States is able to exercise primary supervision over its administration and (2) one or more United States persons have the authority to control all of the substantial decisions of such trust.
|
|
|
·
|
such gain is effectively connected with your conduct of a trade or business in the United States; or
|
|
|
·
|
you are an individual and have been present in the United States for 183 days or more in the taxable year of such sale or exchange and certain other conditions are met.
|
|
|
·
|
at least 50 percent of the average value of its gross assets (based on the quarterly value of such gross assets) is attributable to assets that produce “passive income” or are held for the production of passive income.
|
|
|
·
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
|
|
·
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors;
|
|
|
·
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
|
Year ended December, 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(in thousands of U.S. dollars)
|
||||||||
|
Audit Fees
(1)
|
$ | 170 | $ | 510 | ||||
|
Audit-Related Fees
(2)
|
- | 70 | ||||||
|
Tax Fees
(3)
|
10 | 20 | ||||||
|
All Other Fees
(4)
|
40 | 50 | ||||||
|
Total
|
$ | 220 | $ | 650 | ||||
|
(1)
|
”Audit fees” include fees for services performed by our independent public accounting firm in connection with our annual audit for 2010 and 2011, certain procedures regarding our quarterly financial results submitted on Form 6-K, the filing of our Form F-3, fees related to the secondary public offering and consultation concerning financial accounting and reporting standards.
|
|
(2)
|
“Audit-Related fees” include fees for the performance of due diligence investigations.
|
|
(3)
|
“Tax fees” include fees for professional services rendered by our independent registered public accounting firm for tax compliance and tax advice on actual or contemplated transactions.
|
|
(4)
|
“Other fees” include fees for services rendered by our independent registered public accounting firm with respect to government incentives, transfer pricing and other matters.
|
|
|
·
|
We follow the requirements of Israeli law with respect to the quorum requirement for meetings of our shareholders, which are different from the requirements of Rule 5620(c). Under our articles of association, the quorum required for an ordinary meeting of shareholders consists of at least two shareholders present in person, by proxy or by written ballot, who hold or represent between them at least 25% of the voting power of our shares, instead of 33 1/3% of the issued share capital provided by under the NASDAQ Global Market requirements. This quorum requirement is based on the default requirement set forth in the Companies Law, 1999, or the Companies Law. We submitted a letter from our outside counsel in connection with this item prior to our initial public offering in November 2006.
|
|
|
·
|
We do not seek shareholder approval for equity compensation plans in accordance with the requirements of the Companies Law, which does not fully reflect the requirements of Rule 5635(c). Under Israeli law, we may amend our 2006 Incentive Compensation Plan by the approval of our board of directors, and without shareholder approval as is generally required under Rule 5635(c). Under Israeli law, the adoption and amendment of equity compensation plans, including changes to the reserved shares, do not require shareholder approval. We submitted a letter from our outside counsel in connection with this item in June 2008.
|
|
|
·
|
We do not comply with the requirement that a majority of our board consist of independent directors as required by Rule 5605(b). Israeli law requires that an Israeli company whose securities are listed for trading on a stock exchange outside of Israel have two members of its board of directors that are “external directors” (as defined under the Companies Law) with qualifications (including financial, accounting and professional capabilities as required by the Companies Law) and additional directors with financial, accounting and professional capabilities as determined by the board of directors. The Companies Law also requires that at least three members be appointed to the audit committee, including all of the "external directors," that a majority of the members of such committee should be "independent directors" (as defined under the Companies Law) and that certain persons (e.g., the chairperson or any controlling shareholders) not be appointed as members of such committee. We submitted a letter from our outside counsel in connection with this item in December 2011.
|
|
Allot Communications Ltd.
|
|||
|
|
By:
|
/s/ Rami Hadar | |
|
Rami Hadar
|
|||
|
Chief Executive Officer and President
|
|||
|
Number
|
Description
|
|
|
1.1
|
Articles of Association of the Registrant
(1)
|
|
|
1.2
|
Certificate of Name Change
(1)
|
|
|
2.1
|
Specimen share certificate
(1)
|
|
|
4.1
|
Non-Stabilized Lease Agreement, dated February 13, 2006, by and among, Aderet Hod Hasharon Ltd., Miritz, Inc., Leah and Israel Ruben Assets Ltd., Tamar and Moshe Cohen Assets Ltd., Drish Assets Ltd., S. L. A. A. Assets and Consulting Ltd., Iris Katz Ltd., Y. A. Groder Investments Ltd., Ginotel Hod Hasharon 2000 Ltd. and Allot Communications Ltd.
(1)
|
|
|
4.2
|
Key Employees of Subsidiaries and Consultants Share Incentive Plan (1997)
(1)
|
|
|
4.3
|
Key Employees Share Incentive Plan (1997)
(1)
|
|
|
4.4
|
Key Employees Share Incentive Plan (2003)
(1)
|
|
|
4.5
|
2006 Incentive Compensation Plan
(2)
|
|
|
4.6
|
Manufacturing Agreement, dated July 19, 2007, by and between Flextronics (Israel) Ltd. and the Registrant*
(3)
|
|
|
8.1
|
List of Subsidiaries of the Registrant
|
|
|
11.1
|
Code of Ethics
(4)
|
|
|
12.1
|
Certification of Principal Executive Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
|
|
|
12.2
|
Certification of Principal Financial Officer required by Rule 13a-14(a) and Rule 15d-14(a) (Section 302 Certifications)
|
|
|
13.1
|
Certification of Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(b) and Rule 15d-14(b) (Section 906 Certifications)
|
|
|
14.1
|
Consent of Kost Forer Gabbay & Kasierer
|
|
(1)
|
Previously filed with the Securities and Exchange Commission on October 31, 2006 pursuant to a registration statement on Form F-1 (File No. 333-138313) and incorporated by reference herein.
|
|
(2)
|
Previously filled with the Securities and Exchange Commission on May 27, 2009 as Exhibit 3.3 to Form 20-F for the year ended December 31, 2008 and incorporated by reference herein.
|
|
(3)
|
Previously filled with the Securities and Exchange Commission on June 27, 2008 as Exhibit 4.11 to Form 20-F for the year ended December 31, 2007 and incorporated by reference herein.
|
|
(4)
|
Previously filled with the Securities and Exchange Commission on June 28, 2007 as Exhibit 4 to Form 20-F for the year ended December 31, 2006 and incorporated by reference herein.
|
|
(5)
|
This document was furnished in accordance with SEC Release Nos. 33-8212 and 34-47551.
|
|
*
|
Portions of this exhibit were omitted and have been filed separately with the Secretary of the Securities and Exchange
Commission pursuant to the Registrant’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act.
|
|
Page
|
|
|
F-3 - F-5
|
|
|
F-6 - F-7
|
|
|
F-8
|
|
|
F-9 - F-10
|
|
|
F-11 - F-12
|
|
|
F-13 - F-45
|
|
|
|
Kost Forer Gabbay & Kasierer
2 Pal-Yam Ave.
Haifa 33095, Israel
Tel: 972 (4)8654000
Fax: 972(3)
5633443
www.ey.com
|
| /s/ KOST FORER GABBAY & KASIERER | |||
|
Tel Aviv, Israel
|
KOST FORER GABBAY & KASIERER
|
||
|
April 17, 2012
|
A Member of Ernst & Young Global
|
||
|
Kost Forer Gabbay & Kasierer
2 Pal-Yam Ave.
Haifa 33095, Israel
Tel: 972 (4)8654000
Fax: 972(3)
5633443
www.ey.com
|
|
Kost Forer Gabbay & Kasierer
2 Pal-Yam Ave.
Haifa 33095, Israel
Tel: 972 (4)8654000
Fax: 972(3)
5633443
www.ey.com
|
| /s/ KOST FORER GABBAY & KASIERER | |
|
Tel Aviv, Israel
|
KOST FORER GABBAY & KASIERER
|
|
April 17, 2012
|
A Member of Ernst & Young Global
|
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$ | 116,682 | $ | 42,858 | ||||
|
Restricted cash and deposits
|
1,138 | 1,060 | ||||||
|
Short-term bank deposits
|
24,000 | - | ||||||
|
Available-for-sale marketable securities
|
17,580 | 15,531 | ||||||
|
Trade receivables (net of allowance for doubtful accounts of $ 511 and $ 374 at December 31, 2011 and 2010, respectively)
|
11,926 | 10,739 | ||||||
|
Other receivables and prepaid expenses
|
5,950 | 4,958 | ||||||
|
Inventories
|
10,501 | 10,830 | ||||||
|
Total
current assets
|
187,777 | 85,976 | ||||||
|
NON-CURRENT ASSETS:
|
||||||||
|
Severance pay fund
|
178 | 162 | ||||||
|
Other assets
|
356 | 340 | ||||||
|
Total
non-current assets
|
534 | 502 | ||||||
|
PROPERTY AND EQUIPMENT, NET
|
5,352 | 5,193 | ||||||
|
GOODWILL AND INTANGIBLE ASSETS, NET
|
3,395 | 3,516 | ||||||
|
Total
assets
|
$ | 197,058 | $ | 95,187 | ||||
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
$ | 2,684 | $ | 5,140 | ||||
|
Employees and payroll accruals
|
5,050 | 5,798 | ||||||
|
Deferred revenues
|
16,694 | 10,828 | ||||||
|
Other payables and accrued expenses
|
4,412 | 4,369 | ||||||
|
Total
current liabilities
|
28,840 | 26,135 | ||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Deferred revenues
|
5,430 | 3,873 | ||||||
|
Accrued severance pay
|
219 | 191 | ||||||
|
Total
long-term liabilities
|
5,649 | 4,064 | ||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
SHAREHOLDERS' EQUITY:
|
||||||||
|
Share capital -
|
||||||||
|
Ordinary shares of NIS 0.1 par value - Authorized: 200,000,000 shares at December 31, 2011 and 2010; Issued
and outstanding: 30,950,234 and 23,806,313 shares at December 31, 2011 and 2010, respectively
|
720 | 527 | ||||||
|
Additional paid-in capital
|
223,306 | 133,483 | ||||||
|
Accumulated other comprehensive income (loss)
|
(810 | ) | 434 | |||||
|
Accumulated deficit
|
(60,647 | ) | (69,456 | ) | ||||
|
Total
shareholders' equity
|
162,569 | 64,988 | ||||||
|
Total
liabilities and shareholders' equity
|
$ | 197,058 | $ | 95,187 | ||||
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Revenues:
|
||||||||||||
|
Products
|
$ | 56,810 | $ | 40,852 | $ | 29,641 | ||||||
|
Services
|
20,943 | 16,120 | 12,110 | |||||||||
|
Total
revenues
|
77,753 | 56,972 | 41,751 | |||||||||
|
Cost of revenues:
|
||||||||||||
|
Products
|
19,540 | 14,015 | 10,094 | |||||||||
|
Services
|
2,635 | 1,970 | 1,741 | |||||||||
|
Total
cost of revenues
|
22,175 | 15,985 | 11,835 | |||||||||
|
Gross profit
|
55,578 | 40,987 | 29,916 | |||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development (net of grant participations in the amount of $ 3,674, $ 2,774
and $ 2,440 for the years ended December 31, 2011, 2010 and 2009, respectively
)
|
13,222 | 11,264 | 9,265 | |||||||||
|
Sales and marketing
|
26,543 | 22,021 | 20,408 | |||||||||
|
General and administrative
|
7,474 | 5,473 | 5,541 | |||||||||
|
Total
operating expenses
|
47,239 | 38,758 | 35,214 | |||||||||
|
Operating profit (loss)
|
8,339 | 2,229 | (5,298 | ) | ||||||||
|
Financial expenses (income), net
|
(415 | ) | 7,907 | 2,311 | ||||||||
|
Income (loss) before income tax expenses (benefit)
|
8,754 | (5,678 | ) | (7,609 | ) | |||||||
|
Income tax expenses (benefit)
|
(55 | ) | 84 | 63 | ||||||||
|
Net Income (loss)
|
$ | 8,809 | $ | (5,762 | ) | $ | (7,672 | ) | ||||
| Net earnings (loss) per share: | ||||||||||||
|
Basic
|
$ | 0.35 | $ | (0.25 | ) | $ | (0.35 | ) | ||||
|
Diluted
|
$ | 0.33 | $ | (0.25 | ) | $ | (0.35 | ) | ||||
| Weighted average number of shares used in per share computations of net earnings (loss): | ||||||||||||
|
Basic
|
25,047,771 | 22,831,014 | 22,185,702 | |||||||||
|
Diluted
|
27,071,872 | 22,831,014 | 22,185,702 | |||||||||
|
Ordinary shares
|
Accumulated other comprehensive income (loss) | |||||||||||||||||||||||||||
|
Outstanding shares
|
Amount
|
Additional
paid-in capital
|
Accumulated
deficit
|
Total
comprehensive loss
|
Total
shareholders' equity
|
|||||||||||||||||||||||
|
Balance at January 1, 2009
|
22,067,117 | $ | 482 | $ | 125,703 | $ | 697 | $ | (63,703 | ) | - | $ | 63,179 | |||||||||||||||
|
Exercise of stock options
|
329,945 | 10 | 475 | - | - | - | 485 | |||||||||||||||||||||
|
Compensation related to options granted to non-employees
|
- | - | 58 | - | - | - | 58 | |||||||||||||||||||||
|
Stock-based compensation related to options granted to employees
|
- | - | 2,240 | - | - | - | 2,240 | |||||||||||||||||||||
|
Total comprehensive loss:
|
||||||||||||||||||||||||||||
|
Cumulative effect from adoption of ASC No. 320
|
- | - | - | (7,681 | ) | 7,681 | - | - | ||||||||||||||||||||
|
Unrealized loss on hedging derivative instruments
|
- | - | - | (85 | ) | - | (85 | ) | (85 | ) | ||||||||||||||||||
|
Unrealized gain on available-for-sale marketable securities
|
2,207 | - | 2,207 | 2,207 | ||||||||||||||||||||||||
|
Net loss
|
- | - | - | - | (7,672 | ) | (7,672 | ) | (7,672 | ) | ||||||||||||||||||
|
Total comprehensive loss
|
$ | (5,550 | ) | |||||||||||||||||||||||||
|
Balance at December 31, 2009
|
22,397,062 | $ | 492 | $ | 128,476 | $ | (4,862 | ) | $ | (63,694 | ) | $ | 60,412 | |||||||||||||||
|
Exercise of stock options
|
1,244,051 | 35 | 3,017 | - | - | - | 3,052 | |||||||||||||||||||||
|
Cashless exercise of options
|
165,200 | *) | *) | - | - | - | - | |||||||||||||||||||||
|
Compensation related to options granted to non-employees
|
- | - | 115 | - | - | - | 115 | |||||||||||||||||||||
|
Stock-based compensation related to options granted to employees
|
- | - | 1,875 | - | - | - | 1,875 | |||||||||||||||||||||
|
Total comprehensive loss:
|
||||||||||||||||||||||||||||
|
Unrealized loss on hedging derivative instruments
|
- | - | - | (155 | ) | - | (155 | ) | (155 | ) | ||||||||||||||||||
|
Unrealized loss on available-for-sale marketable securities
|
- | - | - | (23 | ) | - | (23 | ) | (23 | ) | ||||||||||||||||||
|
Realized loss on available-for-sale marketable securities (see Note 3)
|
- | - | - | 5,474 | - | - | 5,474 | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | (5,762 | ) | (5,762 | ) | (5,762 | ) | ||||||||||||||||||
|
Total comprehensive loss
|
$ | (5,940 | ) | |||||||||||||||||||||||||
|
Balance at December 31, 2010
|
23,806,313 | $ | 527 | $ | 133,483 | $ | 434 | $ | (69,456 | ) | $ | 64,988 | ||||||||||||||||
|
Ordinary shares
|
Accumulated other comprehensive income (loss) | Total comprehensive income (loss) | ||||||||||||||||||||||||||
|
Outstanding shares
|
Amount
|
Additional
paid-in capital
|
Accumulated
deficit
|
Total
shareholders' equity
|
||||||||||||||||||||||||
|
Issuance of shares capital related to secondary offering, net of issuance costs *)
|
6,325,000 | 169 | 84,753 | - | - | - | 84,922 | |||||||||||||||||||||
|
Exercise of stock options
|
818,921 | 24 | 2,814 | - | - | - | 2,838 | |||||||||||||||||||||
|
Stock-based compensation related to options granted to employees
|
- | - | 2,256 | - | - | - | 2,256 | |||||||||||||||||||||
|
Total comprehensive loss:
|
||||||||||||||||||||||||||||
|
Unrealized loss on hedging derivative instruments
|
- | - | - | (1,312 | ) | - | (1,312 | ) | (1,312 | ) | ||||||||||||||||||
|
Unrealized gain on available-for-sale marketable securities
|
- | - | - | 68 | - | 68 | 68 | |||||||||||||||||||||
|
Net Income
|
- | - | - | - | 8,809 | 8,809 | 8,809 | |||||||||||||||||||||
|
Total comprehensive income
|
$ | 7,565 | ||||||||||||||||||||||||||
|
Balance at December 31, 2011
|
30,950,234 | $ | 720 | $ | 223,306 | $ | (810 | ) | $ | (60,647 | ) | $ | 162,569 | |||||||||||||||
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Accumulated unrealized gain (loss) on available-for-sale marketable securities
|
$ | 45 | $ | (23 | ) | $ | (5,474 | ) | ||||
|
Accumulated unrealized gain (loss) on foreign currency cash flows hedges
|
(855 | ) | 457 | 612 | ||||||||
|
Accumulated other comprehensive income (loss)
|
$ | (810 | ) | $ | 434 | $ | (4,862 | ) | ||||
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net Income (loss)
|
$ | 8,809 | $ | (5,762 | ) | $ | (7,672 | ) | ||||
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
||||||||||||
|
Depreciation
|
2,754 | 2,577 | 2,468 | |||||||||
|
Write-off of property and of equipment, net
|
- | - | 385 | |||||||||
|
Stock-based compensation related to options granted to employees and non-employees
|
2,256 | 1,990 | 2,298 | |||||||||
|
Amortization of intangible assets
|
124 | 123 | 116 | |||||||||
|
Capital loss (gain)
|
7 | 70 | (108 | ) | ||||||||
|
Decrease (increase) in accrued severance pay, net
|
12 | 75 | (180 | ) | ||||||||
|
Decrease in other assets
|
98 | 41 | 43 | |||||||||
|
Decrease (increase) in accrued interest and amortization of premium on marketable securities
|
151 | (189 | ) | 2 | ||||||||
|
Increase in trade receivables
|
(1,187 | ) | (2,897 | ) | (1,679 | ) | ||||||
|
Increase in other receivables and prepaid expenses
|
(1,083 | ) | (1,495 | ) | (1,661 | ) | ||||||
|
Decrease (increase) in inventories, net
|
329 | (5,784 | ) | (787 | ) | |||||||
|
Decrease (increase) in long-term deferred taxes
|
(114 | ) | 49 | 316 | ||||||||
|
Increase (decrease) in trade payables
|
(2,456 | ) | 1,998 | 240 | ||||||||
|
Increase (decrease) in employees and payroll accruals
|
(748 | ) | 1,868 | 606 | ||||||||
|
Increase in deferred revenues
|
7,423 | 7,188 | 745 | |||||||||
|
Increase (decrease) in other payables and accrued expenses
|
(1,178 | ) | (213 | ) | 1,440 | |||||||
|
Realized loss related to sale of available-for-sale marketable securities
|
- | 7,712 | - | |||||||||
|
Other than temporary loss on marketable securities, net
|
- | - | 3,036 | |||||||||
|
Net cash provided by (used in) operating activities
|
15,197 | 7,351 | (392 | ) | ||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Increase in restricted cash and deposits
|
(78 | ) | - | (2 | ) | |||||||
|
Investments in short-term bank deposits
|
(24,000 | ) | - | (201 | ) | |||||||
|
Redemption of short-term bank deposits.
|
- | 1,264 | - | |||||||||
|
Purchase of property and equipment
|
(2,953 | ) | (2,334 | ) | (3,608 | ) | ||||||
|
Proceeds from sale of property and equipment
|
30 | 168 | 159 | |||||||||
|
Investment in available-for sale marketable securities
|
(4,735 | ) | (16,765 | ) | - | |||||||
|
Proceeds from redemption or sale of available-for-sale marketable securities
|
2,603 | 13,652 | - | |||||||||
|
Net cash used in investing activities
|
(29,133 | ) | (4,015 | ) | (3,652 | ) | ||||||
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Issuance of shares related to secondary offering, net
|
84,922 | - | - | |||||||||
|
Exercise of stock options
|
2,838 | 3,052 | 485 | |||||||||
|
Net cash provided by financing activities
|
87,760 | 3,052 | 485 | |||||||||
|
Increase (decrease) in cash and cash equivalents
|
73,824 | 6,388 | (3,559 | ) | ||||||||
|
Cash and cash equivalents at the beginning of the year
|
42,858 | 36,470 | 40,029 | |||||||||
|
Cash and cash equivalents at the end of the year
|
$ | 116,682 | $ | 42,858 | $ | 36,470 | ||||||
|
Supplementary cash flow information:
|
||||||||||||
|
Cash paid during the year for:
|
||||||||||||
|
Taxes
|
$ | 100 | $ | 168 | $ | 80 | ||||||
|
NOTE 1:-
|
GENERAL
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES
|
|
|
a.
|
Use of estimates:
|
|
|
b.
|
Financial statements in U.S. dollars:
|
|
|
c.
|
Principles of consolidation:
|
|
|
d.
|
Cash and cash equivalents:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
e.
|
Restricted cash and deposits:
|
|
|
f.
|
Short-term bank deposits:
|
|
|
g.
|
Marketable securities:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
h.
|
Inventories:
|
|
|
Cost is determined as follows:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
i.
|
Property and equipment:
|
|
%
|
||
|
Lab equipment
|
25 - 33
|
|
|
Computers and peripheral equipment
|
15 - 33
|
|
|
Office furniture
|
6 - 15
|
|
|
Leasehold improvements
|
By the shorter of term of the lease or the useful life of the asset
|
|
|
j.
|
Goodwill impairment:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
k.
|
Impairment of long-lived assets:
|
|
|
l.
|
Revenue recognition
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
m.
|
Advertising expenses:
|
|
|
n.
|
Research and development costs:
|
|
|
o.
|
Severance pay:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
p.
|
Accounting for stock-based compensation:
|
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Cost of revenues
|
$ | 103 | $ | 95 | $ | 104 | ||||||
|
Research and development
|
442 | 352 | 357 | |||||||||
|
Sales and marketing
|
1,001 | 851 | 775 | |||||||||
|
General and administrative
|
710 | 692 | 1,062 | |||||||||
|
Total stock-based compensation expense
|
$ | 2,256 | $ | 1,990 | $ | 2,298 | ||||||
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Suboptimal exercise multiple
|
2.5-3.5 | 2.5-3.5 | 2.5-3.5 | |||||||||
|
Risk free interest rate
|
0.11%-5.46% | 0.25%-5.54% | 0.31%-5.19% | |||||||||
|
Volatility
|
50%-53% | 50%-52% | 53%-60% | |||||||||
|
Dividend yield
|
0% | 0% | 0% | |||||||||
|
|
q.
|
Concentration of credit risks:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
r.
|
Royalty bearing grants:
|
|
|
s.
|
Income taxes:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
t.
|
Basic and diluted net loss per share:
|
|
|
u.
|
Comprehensive income (loss):
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
v.
|
Fair value of financial instruments:
|
|
|
Level 1 -
|
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
|
|
|
Level 2 -
|
Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and
|
|
|
Level 3 -
|
Unobservable inputs which are supported by little or no market activity.
|
|
|
w.
|
Derivatives and hedging:
|
|
NOTE 2:-
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
x.
|
Warranty costs:
|
|
|
y.
|
Recently issued accounting standards:
|
|
NOTE 3:-
|
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
|
|
December 31, 2011
|
December 31, 2010
|
|||||||||||||||||||||||||||||||
|
Amortized cost
|
Gross unrealized gain
|
Gross unrealized
loss
|
Fair
value
|
Amortized cost
|
Gross
unrealized
gain
|
Gross unrealized
loss
|
Fair
value
|
|||||||||||||||||||||||||
|
Available-for-sale - matures within one year:
|
||||||||||||||||||||||||||||||||
|
Governmental debentures
|
$ | 251 | $ | - | $ | - | $ | 251 | $ | 1,022 | $ | 1 | $ | - | $ | 1,023 | ||||||||||||||||
|
Federal Home Loan Bank
|
- | - | - | - | 807 | - | - | 807 | ||||||||||||||||||||||||
|
Corporate debentures
|
2,237 | 2 | (1 | ) | 2,238 | 210 | 3 | - | 213 | |||||||||||||||||||||||
| 2,488 | 2 | (1 | ) | 2,489 | 2,039 | 4 | - | 2,043 | ||||||||||||||||||||||||
|
Available-for-sale - matures after one year through three years:
|
||||||||||||||||||||||||||||||||
|
Governmental debentures
|
7,782 | 24 | - | 7,806 | 8,418 | 1 | (4 | ) | 8,415 | |||||||||||||||||||||||
|
Federal Home Loan Bank
|
- | - | - | - | 201 | - | (1 | ) | 200 | |||||||||||||||||||||||
|
Corporate debentures
|
7,265 | 29 | (9 | ) | 7,285 | 4,896 | - | (23 | ) | 4,873 | ||||||||||||||||||||||
| 15,047 | 53 | (9 | ) | 15,091 | 13,515 | 1 | (28 | ) | 13,488 | |||||||||||||||||||||||
| $ | 17,535 | $ | 55 | $ | (10 | ) | $ | 17,580 | $ | 15,554 | $ | 5 | $ | (28 | ) | $ | 15,531 | |||||||||||||||
|
NOTE4:-
|
FAIR VALUE MEASUREMENTS
|
|
NOTE4:-
|
FAIR VALUE MEASUREMENTS (Cont.)
|
|
As of December 31, 2011
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Available-for-sale marketable securities
|
$ | - | $ | 17,580 | $ | - | $ | 17,580 | ||||||||
|
Foreign currency derivative contracts
|
- | (638 | ) | - | (638 | ) | ||||||||||
|
Total financial assets
|
$ | - | $ | 16,942 | $ | - | $ | 16,942 | ||||||||
|
As of December 31, 2010
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Treasury Bills
|
$ | 12,548 | $ | - | $ | - | $ | 12,548 | ||||||||
|
Available-for-sale marketable securities
|
- | 15,531 | - | 15,531 | ||||||||||||
|
Foreign currency derivative contracts
|
- | 412 | - | 412 | ||||||||||||
|
Total financial assets
|
$ | 12,548 | $ | 15,943 | $ | - | $ | 28,491 | ||||||||
|
NOTE4:-
|
FAIR VALUE MEASUREMENTS (Cont.)
|
|
|
Fair value measurements using significant unobservable inputs (Level 3):
|
|
Marketable Securities
|
||||
|
Balance at January 1, 2009
|
$ | 15,319 | ||
|
Total gains and losses (realized and unrealized)
|
- | |||
|
Included in financial and other expenses, net
|
(3,036 | ) | ||
|
Included in other comprehensive loss
|
2,207 | |||
|
Purchases and sales
|
- | |||
|
Balance at December 31, 2009
|
14,490 | |||
|
Total gains and losses (realized and unrealized)
|
||||
|
Included in financial and other expenses, net
|
(2,238 | ) | ||
|
Included in other comprehensive loss
|
- | |||
|
Purchases and sales
|
(12,252 | ) | ||
|
Balance at December 31, 2010
|
$ | - | ||
|
NOTE 5:-
|
DERIVATIVE INSTRUMENTS
|
|
NOTE 5:-
|
DERIVATIVE INSTRUMENTS (Cont.)
|
|
Foreign exchange forward and
|
December 31,
|
|||||||||
|
options contracts
|
Balance sheet
|
2011
|
2010
|
|||||||
|
Fair value of foreign exchange option contracts
|
Other receivables and prepaid expenses
|
$ | 25 | $ | 167 | |||||
|
Fair value of foreign exchange forward contracts, net
|
Other receivables and prepaid expenses (Other payables and accrued expenses)
|
(880 | ) | 290 | ||||||
|
Total derivatives designated as hedging instrument
|
$ | (855 | ) | $ | 457 | |||||
|
Total derivatives not designated as hedging instrument, net
|
Other receivables and prepaid expenses (Other payables and accrued expenses)
|
$ | 217 | $ | (45 | ) | ||||
|
NOTE 5:-
|
DERIVATIVE INSTRUMENTS (Cont.)
|
|
NOTE 6:-
|
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES
|
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Prepaid expenses
|
$ | 3,288 | $ | 1,482 | ||||
|
Short-term lease deposits
|
188 | 195 | ||||||
|
Other receivable from insurance carrier in regard of class action (see Note 11)
|
- | 1,300 | ||||||
|
Government authorities
|
1,043 | 1,056 | ||||||
|
Grants receivable from the OCS
|
556 | 272 | ||||||
|
Foreign currency derivative contracts
|
368 | 457 | ||||||
|
Others
|
507 | 196 | ||||||
| $ | 5,950 | $ | 4,958 | |||||
|
NOTE 7:-
|
INVENTORIES
|
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Raw materials
|
$ | 1,155 | $ | 1,071 | ||||
|
Finished products
|
9,346 | 9,759 | ||||||
| $ | 10,501 | $ | 10,830 | |||||
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Cost:
|
||||||||
|
Lab equipment
|
$ | 10,841 | $ | 9,270 | ||||
|
Computers and peripheral equipment
|
7,604 | 6,535 | ||||||
|
Office furniture and equipment
|
439 | 419 | ||||||
|
Leasehold improvements
|
596 | 527 | ||||||
| 19,480 | 16,751 | |||||||
|
Accumulated depreciation:
|
||||||||
|
Lab equipment
|
7,814 | 6,466 | ||||||
|
Computers and peripheral equipment
|
5,687 | 4,549 | ||||||
|
Office furniture and equipment
|
241 | 213 | ||||||
|
Leasehold improvements
|
386 | 330 | ||||||
| 14,128 | 11,558 | |||||||
|
Depreciated cost
|
$ | 5,352 | $ | 5,193 | ||||
|
NOTE 9:-
|
INTANGIBLE ASSETS, NET
|
|
|
a.
|
The following table shows the Company's intangible assets for the periods presented:
|
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Cost:
|
||||||||
|
Core technology (1)
|
$ | 726 | $ | 726 | ||||
|
Accumulated amortization
|
482 | 358 | ||||||
|
Amortized cost
|
$ | 244 | $ | 368 | ||||
|
|
(1)
|
Core technology was recorded in 2008 following the acquisition of the tangible and the intangible assets of Esphion limited. The Company amortizes the intangible assets using the straight-line method over a period of six years, which constitutes the number of years that approximate the pattern in which the economic benefits of the intangible assets will be consumed.
|
|
NOTE 9:-
|
INTANGIBLE ASSETS, NET (Cont.)
|
|
|
b.
|
Amortization expense for the years ended December 31, 2011, 2010 and 2009 were $ 124, $ 123 and $ 116, respectively.
|
|
|
c.
|
Estimated amortization expense for the years ending:
|
|
Year ending December 31,
|
||||
|
2012
|
$ | 122 | ||
|
2013
|
122 | |||
|
Total
|
$ | 244 | ||
|
NOTE 10:-
|
OTHER PAYABLES AND ACCRUED EXPENSES
|
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Accrued expenses
|
$ | 1,701 | $ | 1,581 | ||||
|
Other payable in regard of class action (see Note 11c)
|
- | 1,300 | ||||||
|
Accrued royalties to the OCS
|
1,364 | 1,157 | ||||||
|
Foreign currency derivative contracts
|
1,006 | 45 | ||||||
|
Others
|
341 | 286 | ||||||
| $ | 4,412 | $ | 4,369 | |||||
|
NOTE 11:-
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
|
a.
|
Royalties:
|
|
NOTE 11:-
|
COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
|
|
|
b.
|
Lease commitments:
|
|
Year ending December 31,
|
||||
|
2012
|
$ | 1,235 | ||
|
2013
|
713 | |||
|
2014
|
171 | |||
|
2015
|
22 | |||
|
2016
|
22 | |||
|
2017
|
11 | |||
|
Total
|
$ | 2,174 | ||
|
NOTE 11:-
|
COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
|
|
|
c.
|
Lawsuit:
|
|
|
d.
|
Major subcontractor:
|
|
NOTE 12:-
|
SHAREHOLDERS' EQUITY
|
|
|
a.
|
Company's shares
|
|
|
b.
|
Warrants
|
|
|
c.
|
Stock option plan:
|
|
Year ended December 31,
|
||||||||||||||||||||||||
|
2011
|
2010
|
2009
|
||||||||||||||||||||||
|
Number
of shares upon exercise
|
Weighted average exercise price
|
Number
of shares upon exercise
|
Weighted average exercise price
|
Number
of shares upon exercise
|
Weighted average exercise price
|
|||||||||||||||||||
|
Outstanding at beginning of year
|
3,427,870 | $ | 3.81 | 4,081,683 | $ | 3.07 | 4,069,505 | $ | 3.54 | |||||||||||||||
|
Granted
|
649,000 | $ | 14.31 | 906,850 | $ | 5.36 | 1,055,497 | $ | 3.05 | |||||||||||||||
|
Forfeited
|
(93,859 | ) | $ | 8.57 | (316,612 | ) | $ | 3.89 | (713,374 | ) | $ | 6.46 | ||||||||||||
|
Exercised
|
(818,921 | ) | $ | 3.46 | (1,244,051 | ) | $ | 2.50 | (329,945 | ) | $ | 1.47 | ||||||||||||
|
Outstanding at end of year
|
3,164,090 | $ | 5.90 | 3,427,870 | $ | 3.81 | 4,081,683 | $ | 3.07 | |||||||||||||||
|
Exercisable at end of year
|
1,592,432 | $ | 3.66 | 1,638,086 | $ | 3.46 | 2,226,413 | $ | 3.12 | |||||||||||||||
|
Vested and Expected to Vest
|
2,324,031 | $ | 4.80 | 3,019,542 | $ | 3.7 | 2,143,854 | $ | 3.33 | |||||||||||||||
|
NOTE 12:-
|
SHAREHOLDERS' EQUITY (Cont.)
|
|
Exercise price
|
Shares upon exercise of options outstanding as of December 31, 2011
|
Weighted average remaining contractual life
|
Shares upon exercise of options exercisable as of December 31, 2011
|
|||||||||||
|
Years
|
||||||||||||||
| $ | 16.82 | 15,000 | 9.93 | - | ||||||||||
| $ | 15.2-15.43 | 338,250 | 9.19 | 4,875 | ||||||||||
| $ | 14.4-14.52 | 224,500 | 9.75 | - | ||||||||||
| $ | 9.7-11.34 | 30,000 | 5.15 | 30,000 | ||||||||||
| $ | 7.25-9.25 | 307,900 | 8.70 | 96,178 | ||||||||||
| $ | 5.7-6.59 | 19,538 | 5.67 | 19,538 | ||||||||||
| $ | 4.02-5.25 | 597,254 | 8.00 | 248,932 | ||||||||||
| $ | 3.00-4.00 | 903,336 | 5.78 | 714,648 | ||||||||||
| $ | 1.92-2.97 | 613,818 | 6.76 | 426,890 | ||||||||||
| $ | 1.205-1.56 | 33,248 | 4.70 | 24,185 | ||||||||||
| $ | 0.002-0.026 | 81,246 | 8.45 | 27,186 | ||||||||||
| 3,164,090 | 1,592,432 | |||||||||||||
|
NOTE 12:-
|
SHAREHOLDERS' EQUITY (Cont.)
|
|
NOTE 13:-
|
TAXES ON INCOME
|
|
|
a.
|
Corporate tax rates: Amendment to the Israeli Income Tax Ordinance
The Israeli corporate tax rate was 26% in 2009, 25% in 2010 and 24% in 2011.
|
|
|
b.
|
Tax benefits under Israel's law for the Encouragement of Capital Investments, 1959 ("the Law"):
|
|
NOTE 13:-
|
TAXES ON INCOME (Cont.)
|
|
NOTE 13:-
|
TAXES ON INCOME (Cont.)
|
|
|
d.
|
Tax benefits under the law for the Encouragement of Industry (Taxes), 1969 ("the Encouragement Law"):
|
|
NOTE 13:-
|
TAXES ON INCOME (Cont.)
|
|
|
e.
|
Pre-tax income (loss) is comprised as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Domestic
|
$ | 9,737 | $ | (6,637 | ) | $ | (7,558 | ) | ||||
|
Foreign
|
(983 | ) | 959 | (51 | ) | |||||||
| $ | 8,754 | $ | (5,678 | ) | $ | (7,609 | ) | |||||
|
|
f.
|
A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Income (loss) before taxes on income
|
$ | 8,754 | $ | (5,678 | ) | $ | (7,609 | ) | ||||
|
Theoretical tax expense (benefit) computed at the Israeli statutory tax rate
(24%, 25% and 26% for the years 2011, 2010 and 2009, respectively)
|
$ | 2,101 | $ | (1,419 | ) | $ | (1,978 | ) | ||||
|
Losses and temporary differences, net in respect of which no deferred taxes were recorded
|
1,091 | 728 | 1,738 | |||||||||
|
Taxes with respect to prior years
|
(84 | ) | 35 | (189 | ) | |||||||
|
Change in expense associated with tax positions for current year
|
- | - | (210 | ) | ||||||||
|
Impairment (recording) of withholding tax asset
|
221 | (53 | ) | 29 | ||||||||
|
Non-deductible expenses and other
|
42 | 60 | 70 | |||||||||
|
Non-deductible share-based compensation expenses
|
541 | 499 | 597 | |||||||||
|
Exchange rate differences and others
|
(3,967 | ) | 234 | 6 | ||||||||
|
Actual tax expenses (benefit)
|
$ | (55 | ) | $ | 84 | $ | 63 | |||||
|
NOTE 13:-
|
TAXES ON INCOME (Cont.)
|
|
|
g.
|
Income tax expense (tax benefit) is comprised as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Current taxes
|
$ | 31 | $ | 109 | $ | 113 | ||||||
|
Deferred taxes
|
(223 | ) | (7 | ) | 320 | |||||||
|
Taxes in respect of previous years
|
(84 | ) | 35 | (189 | ) | |||||||
|
Change in expense associated with tax positions for current year
|
- | - | (210 | ) | ||||||||
|
Impairment (recording) of withholding tax asset
|
221 | (53 | ) | 29 | ||||||||
| $ | (55 | ) | $ | 84 | $ | 63 | ||||||
|
|
h.
|
Net operating losses carry forward:
|
|
NOTE 13:-
|
TAXES ON INCOME (Cont.)
|
|
|
i.
|
Deferred income taxes:
|
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Operating and capital loss carry forward
|
$ | 16,003 | $ | 13,539 | ||||
|
Reserves and allowances
|
1,759 | 2,905 | ||||||
|
Deferred tax asset before valuation allowance
|
17,762 | 16,444 | ||||||
|
Valuation allowance
|
(17,378 | ) | (16,287 | ) | ||||
|
Net deferred tax asset
|
$ | 384 | $ | 157 | ||||
|
|
j.
|
As of December 31, 2011 and 2010, the provision in resepect of ASC740 was $ 75. The Company accrues interest and penalties related to the provision in income taxes in its statement of operations. Such interest and penalties were immaterial for all reported periods .
|
|
NOTE 14:-
|
GEOGRAPHIC INFORMATION
|
|
|
Allot operates in a single reportable segment. Revenues are based on the customer's location:
|
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Europe
|
$ | 38,409 | $ | 30,434 | $ | 18,735 | ||||||
|
Asia and Oceania
|
13,388 | 12,469 | 11,004 | |||||||||
|
United States of America
|
9,484 | 7,680 | 6,316 | |||||||||
|
Middle East and Africa
|
9,530 | 3,890 | 2,992 | |||||||||
|
Americas (excluding United States of America)
|
6,942 | 2,499 | 2,704 | |||||||||
| $ | 77,753 | $ | 56,972 | $ | 41,751 | |||||||
|
December 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Long-lived assets:
|
||||||||
|
Israel
|
$ | 8,653 | $ | 8,650 | ||||
|
United States of America
|
300 | 265 | ||||||
|
Other
|
150 | 134 | ||||||
| $ | 9,103 | $ | 9,049 | |||||
|
NOTE 15:-
|
FINANCIAL AND OTHER EXPENSES, NET
|
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Financial income:
|
||||||||||||
|
Interest income
|
$ | (661 | ) | $ | (492 | ) | $ | (914 | ) | |||
|
Financial expenses:
|
||||||||||||
|
Interest expense
|
16 | 216 | 137 | |||||||||
|
Foreign currency transactions differences
|
230 | 471 | 52 | |||||||||
|
Impairment related to Auction-Rate Securities, net
|
- | 7,712 | 3,036 | |||||||||
| $ | (415 | ) | $ | 7,907 | $ | 2,311 | ||||||
|
Year ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Numerator:
|
||||||||||||
|
Net income (loss)
|
$ | 8,809 | $ | (5,678 | ) | $ | (7,672 | ) | ||||
|
Denominator:
|
||||||||||||
|
Weighted average number of shares outstanding used in computing basic net earnings per share
|
25,047,771 | 22,831,014 | 22,185,702 | |||||||||
|
Dilutive effect: stock options
|
2,024,101 | - | - | |||||||||
|
Total weighted average number of shares used in computing diluted net earnings per share
|
27,071,872 | 22,831,014 | 22,185,702 | |||||||||
|
Basic net earnings (loss) per share
|
$ | 0.35 | $ | (0.25 | ) | $ | (0.35 | ) | ||||
|
Diluted net income per share
|
$ | 0.33 | $ | (0.25 | ) | $ | (0.35 | ) | ||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|